Bolt Biotherapeutics Stock (NASDAQ: BOLT) stock price, news, charts, stock research, profile.
You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.
Other companies in Bolt Biotherapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), NKGen Biotech (NASDAQ:NKGN), HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM) and Coeptis Therapeutics (NASDAQ:COEP).
Bolt Biotherapeutics has a consensus price target of $2.38.
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $0.5026 last updated January 17, 2025 at 8:28 AM EST.
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2014 to stockholders of record on September 1, 2014.
Bolt Biotherapeutics’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for Bolt Biotherapeutics.
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.